ArticleOncoimmunology2023
Enhancing T cell anti-tumor efficacy with a PD1-TIGIT chimeric immune-checkpoint switch receptor.
Jingjing Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ArticleOncoimmunology2023
Jingjing Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.